126 related articles for article (PubMed ID: 10407361)
1. Electrospray ionization mass spectrometric method for the determination of cannabinoid precursors: N-acylethanolamine phospholipids (NAPEs).
Hansen HH; Hansen SH; Bjørnsdottir I; Hansen HS
J Mass Spectrom; 1999 Jul; 34(7):761-7. PubMed ID: 10407361
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function.
Schmid HH; Berdyshev EV
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):363-76. PubMed ID: 12052050
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways.
Tsuboi K; Okamoto Y; Ikematsu N; Inoue M; Shimizu Y; Uyama T; Wang J; Deutsch DG; Burns MP; Ulloa NM; Tokumura A; Ueda N
Biochim Biophys Acta; 2011 Oct; 1811(10):565-77. PubMed ID: 21801852
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death.
Hansen HH; Ikonomidou C; Bittigau P; Hansen SH; Hansen HS
J Neurochem; 2001 Jan; 76(1):39-46. PubMed ID: 11145976
[TBL] [Abstract][Full Text] [Related]
5. Determination of the phospholipid precursor of anandamide and other N-acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neurons.
Hansen HH; Hansen SH; Schousboe A; Hansen HS
J Neurochem; 2000 Aug; 75(2):861-71. PubMed ID: 10899965
[TBL] [Abstract][Full Text] [Related]
6. The neurobiology and evolution of cannabinoid signalling.
Elphick MR; Egertová M
Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
[TBL] [Abstract][Full Text] [Related]
7. Mammalian cells stably overexpressing N-acylphosphatidylethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines.
Okamoto Y; Morishita J; Wang J; Schmid PC; Krebsbach RJ; Schmid HH; Ueda N
Biochem J; 2005 Jul; 389(Pt 1):241-7. PubMed ID: 15760304
[TBL] [Abstract][Full Text] [Related]
8. Putative neuroprotective actions of N-acyl-ethanolamines.
Hansen HS; Moesgaard B; Petersen G; Hansen HH
Pharmacol Ther; 2002 Aug; 95(2):119-26. PubMed ID: 12182959
[TBL] [Abstract][Full Text] [Related]
9. A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry.
Houjou T; Yamatani K; Imagawa M; Shimizu T; Taguchi R
Rapid Commun Mass Spectrom; 2005; 19(5):654-66. PubMed ID: 15700236
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptors and their ligands.
Pertwee RG; Ross RA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
[TBL] [Abstract][Full Text] [Related]
11. Analysis of anandamide, an endogenous cannabinoid substance, and of other natural N-acylethanolamines.
Fontana A; Di Marzo V; Cadas H; Piomelli D
Prostaglandins Leukot Essent Fatty Acids; 1995 Oct; 53(4):301-8. PubMed ID: 8577784
[TBL] [Abstract][Full Text] [Related]
12. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period.
Berrendero F; Sepe N; Ramos JA; Di Marzo V; Fernández-Ruiz JJ
Synapse; 1999 Sep; 33(3):181-91. PubMed ID: 10420166
[TBL] [Abstract][Full Text] [Related]
13. Occurrence, biosynthesis and functions of N-acylphosphatidylethanolamines (NAPE): not just precursors of N-acylethanolamines (NAE).
Coulon D; Faure L; Salmon M; Wattelet V; Bessoule JJ
Biochimie; 2012 Jan; 94(1):75-85. PubMed ID: 21575672
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo.
Simon GM; Cravatt BF
Mol Biosyst; 2010 Aug; 6(8):1411-8. PubMed ID: 20393650
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoids in the immune system and cancer.
Parolaro D; Massi P; Rubino T; Monti E
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):319-32. PubMed ID: 12052046
[TBL] [Abstract][Full Text] [Related]
16. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: a novel enzyme of the beta-lactamase fold family releasing anandamide and other N-acylethanolamines.
Ueda N; Okamoto Y; Morishita J
Life Sci; 2005 Aug; 77(14):1750-8. PubMed ID: 15949819
[TBL] [Abstract][Full Text] [Related]
17. Effect of synthetic and natural phospholipids on N-acylphosphatidylethanolamine-hydrolyzing phospholipase D activity.
Petersen G; Pedersen AH; Pickering DS; Begtrup M; Hansen HS
Chem Phys Lipids; 2009 Nov; 162(1-2):53-61. PubMed ID: 19715685
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway.
Simon GM; Cravatt BF
J Biol Chem; 2006 Sep; 281(36):26465-72. PubMed ID: 16818490
[TBL] [Abstract][Full Text] [Related]
19. Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue.
Kempe K; Hsu FF; Bohrer A; Turk J
J Biol Chem; 1996 Jul; 271(29):17287-95. PubMed ID: 8663381
[TBL] [Abstract][Full Text] [Related]
20. Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: protectors or killers?
Pushkarev VM; Kovzun OI; Tronko MD
Exp Oncol; 2008 Mar; 30(1):6-21. PubMed ID: 18438336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
